cardinal health glp-1 receptor agonist weight management diabetes treatments Frontiers GLP-1 Receptor Agonists for the

Some even suggest that GLP-1 agonists might have the potential to supplant MASH therapy in its entirety

Conflict of interest BG has served as a consultant for AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Merck (MSD) and Novartis as manufacturers of DPP-4 inhibitors and has received honoraria from these companies for lectures

This new avenue has yet to see a standout success, with Orforglipron emerging as a leading contender, showing promising results in blood sugar control and weight management according to clinical trials [14][15]

The terms also note that patients in New York, New Jersey, and Rhode Island have the right to request an itemized price list for laboratory tests

* Correspondence: Peijun Liu, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

As a result of the different frequencies between the antral and duodenal contractions, the duodenum can contract three to four times during an antral wave (red lines in Fig